Evidence map›Paper›PMID 39939120›Full record

ArticleACS applied bio materials2025

Frequency-Selective Microbubble Targeting

Jair I Castillo, J Angel Navarro-Becerra, Ilaria Angelini, Maxim Kokoshinskiy, Mark A Borden

Abstract read
In one paragraph

Article in ACS applied bio materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jair I CastilloBiomedical Engineering Program, University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0003-0395-9252
J Angel Navarro-BecerraMechanical Engineering Department, University of Colorado, Boulder, Colorado 80309, United States.
Ilaria AngeliniBiomedical Engineering Program, University of Colorado, Boulder, Colorado 80309, United States.
Maxim KokoshinskiyBiomedical Engineering Program, University of Colorado, Boulder, Colorado 80309, United States.
Mark A BordenBiomedical Engineering Program, University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0002-2089-983X

Funding

Developing ultrasound contrast agents and signal processing for structural and functional imaging in type 1 diabetesR01DK140904 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Richard KP Benninger, Mark Andrew Borden · 2024 to 2026
$1.9M
Microbubble Dose Optimization for Image-Guided Drug DeliveryR01CA239465 · NCI · UNIVERSITY OF COLORADO · PI BORDEN, MARK ANDREW · 2019 to 2023
$1.7M
NCI NIH HHS R01 CA239465NIDDK NIH HHS R01 DK140904
6 · The paper itself

Abstract

Ultrasound molecular imaging (USMI) utilizing targeted microbubbles (tMBs) and primary acoustic radiation force (

Indexed as

Biocompatible MaterialsContrast MediaMicrobubblesMolecular ImagingHumansIntegrin alphaVbeta3Materials TestingParticle SizeUltrasonographyBiocompatible MaterialsContrast MediaIntegrin alphaVbeta3buried-ligand architectureligand receptor specificityprimary radiation forceresonance frequencysize-isolated microbubbles

Identifiers

PMID39939120
PMCPMC12017267

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.